Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann E Mills

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|August 9, 2011
Human DNA patent renewals on the declineAnn E Mills, Patti Tereskerz
Nature Biotechnology|September 10, 2008
DNA-based patents: an empirical analysisAnn E Mills, Patti Tereskerz
HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues|January 7, 2011
The pre-conditions for "building capacity" in an ethics programAnn E Mills, Mary V Rorty
Nature Biotechnology|April 10, 2010
Empirical analysis of major stem cell patent cases: the role of universitiesAnn E Mills, Patti M Tereskerz
Health Affairs (Project Hope)|July 16, 2002
Recommendations on qualityEdward M Spencer, Ann E Mills
Science (New York, N.Y.)|March 12, 2011
Projecting human DNA patent numbersAnn E Mills, Patti M Tereskerz
HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues|December 23, 2003
Evidence-based medicine: why clinical ethicists should be concernedAnn E Mills, Edward M Spencer
Business Ethics Quarterly : the Journal of the Society for Business Ethics|April 24, 2003
Total quality management and the silent patientAnn E Mills, Mary V Rorty
The New England Journal of Medicine|March 19, 2010
A step in the direction of health insurance reformAnn E Mills, Patricia M Tereskerz
Nature Biotechnology|August 10, 2007
Changing patent strategies: what will they mean for the industry?Ann E Mills, Patti M Tereskerz
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|August 9, 2011
Human DNA patent renewals on the declineAnn E Mills, Patti Tereskerz
Nature Biotechnology|September 10, 2008
DNA-based patents: an empirical analysisAnn E Mills, Patti Tereskerz
HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues|January 7, 2011
The pre-conditions for "building capacity" in an ethics programAnn E Mills, Mary V Rorty
Nature Biotechnology|April 10, 2010
Empirical analysis of major stem cell patent cases: the role of universitiesAnn E Mills, Patti M Tereskerz
Health Affairs (Project Hope)|July 16, 2002
Recommendations on qualityEdward M Spencer, Ann E Mills
Science (New York, N.Y.)|March 12, 2011
Projecting human DNA patent numbersAnn E Mills, Patti M Tereskerz
HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues|December 23, 2003
Evidence-based medicine: why clinical ethicists should be concernedAnn E Mills, Edward M Spencer
Business Ethics Quarterly : the Journal of the Society for Business Ethics|April 24, 2003
Total quality management and the silent patientAnn E Mills, Mary V Rorty
The New England Journal of Medicine|March 19, 2010
A step in the direction of health insurance reformAnn E Mills, Patricia M Tereskerz
Nature Biotechnology|August 10, 2007
Changing patent strategies: what will they mean for the industry?Ann E Mills, Patti M Tereskerz
Pageof 2